Decode
Integrate each tumor’s molecular profile, clinical context, and the evolving oncology evidence base.
Personalized mRNA therapeutics
Decode the tumor.
Write the treatment.
MendCipher Bio is building an AI-guided platform to design personalized mRNA therapeutics from the molecular language of each patient's cancer.
THERAPEUTIC DESIGN / 001 RESEARCH
INPUTPatient-specific tumor profileOUTPUTRanked mRNA design candidates
Computational design · Expert review · Experimental validation
Our thesis
Cancer is personal.
Treatment design should be too.
Every tumor carries a distinct molecular signature. We believe the convergence of mRNA, high-resolution tumor profiling, and modern AI can make individualized therapeutic design faster, more systematic, and more scalable.
The MendCipher platform
From molecular data
to a testable design.
A closed-loop discovery workflow that joins computational intelligence with rigorous experimental science.
Prioritize
Use AI-assisted reasoning to identify patient-specific targets and rank therapeutic hypotheses for expert review.
Encode
Translate selected targets into mRNA construct candidates designed for precise, testable biological activity.
Learn
Close the loop with experimental results to improve future design decisions and accelerate iteration.
How we work
Intelligence with scientific discipline.
Patient-specific
Designed around the biology of one patient, not the statistical average.
Evidence-grounded
AI supports structured synthesis; scientists remain accountable for every decision.
Experiment-ready
Computational hypotheses are built to be tested, measured, and refined in the lab.
Build what comes next
We're at the beginning
of a long mission.
We're interested in hearing from scientists, clinicians, computational biologists, and partners who share our ambition for personalized cancer therapeutics.